Revolution Medicines Inc (42Z)
TG
| 株主 | タイプ | 保有数(実際) | 発行済株式の% | 時価総額 | ポジション日付 |
|---|---|---|---|---|---|
| Farallon Capital Management, L.L.C. | 機関 | 13,604,796 | 6.40% | 1.84B € | 2026-03-31 |
| BlackRock, Inc. | 機関 | 11,212,620 | 5.27% | 1.51B € | 2026-03-31 |
| Janus Henderson Group plc | 機関 | 9,766,496 | 4.59% | 1.32B € | 2026-03-31 |
| Baker Bros. Advisors LP | 機関 | 9,555,357 | 4.49% | 1.29B € | 2026-03-31 |
| FMR LLC | 機関 | 8,452,363 | 3.98% | 1.14B € | 2026-03-31 |
| Farallon Healthcare Partners Master, L.P. | 機関 | 8,420,065 | 3.96% | 1.14B € | 2025-12-31 |
| Vanguard Capital Management, LLC | 機関 | 8,362,284 | 3.93% | 1.13B € | 2026-03-31 |
| Nextech Invest Ltd. | 機関 | 7,601,087 | 3.58% | 1.03B € | 2026-03-31 |
| Vanguard Portfolio Management, LLC | 機関 | 7,502,623 | 3.53% | 1.01B € | 2026-03-31 |
| Paradigm Biocapital Advisors LP | 機関 | 6,655,703 | 3.13% | 898.19M € | 2026-03-31 |
| Wellington Management Group LLP | 機関 | 6,027,819 | 2.84% | 813.45M € | 2026-03-31 |
| Adage Capital Management, L.P. | 機関 | 5,475,611 | 2.58% | 738.93M € | 2026-03-31 |
| UBS Asset Management AG | 機関 | 4,887,386 | 2.30% | 659.55M € | 2026-03-31 |
| State Street Global Advisors, Inc. | 機関 | 4,402,662 | 2.07% | 594.14M € | 2026-03-31 |
| T. Rowe Price Group, Inc. | 機関 | 3,896,260 | 1.83% | 525.80M € | 2026-03-31 |
| Nextech V Oncology S.C.S., SICAV-SIF | 機関 | 3,590,313 | 1.69% | 484.51M € | 2026-03-31 |
| Geode Capital Management, LLC | 機関 | 3,338,142 | 1.57% | 450.48M € | 2026-03-31 |
| GV Management Company, LLC | 機関 | 3,292,525 | 1.55% | 444.33M € | 2026-03-31 |
| BVF Partners L.P. | 機関 | 2,856,782 | 1.34% | 385.52M € | 2026-03-31 |
| Casdin Capital, LLC | 機関 | 2,577,333 | 1.21% | 347.81M € | 2026-03-31 |
| Woodline Partners LP | 機関 | 2,506,570 | 1.18% | 338.26M € | 2026-03-31 |
| Farallon Capital Offshore Investors II, L.P | 機関 | 2,482,796 | 1.17% | 335.05M € | 2025-12-31 |
| Holocene Advisors, LP | 機関 | 2,468,644 | 1.16% | 333.14M € | 2026-03-31 |
| Norges Bank Investment Management | 機関 | 2,455,347 | 1.15% | 331.35M € | 2025-12-31 |
| Vestal Point Capital, LP | 機関 | 2,375,000 | 1.12% | 320.51M € | 2026-03-31 |
| Avoro Capital Advisors LLC | 機関 | 2,344,444 | 1.10% | 316.38M € | 2026-03-31 |
| Mr. Alexis Borisy | インサイダー | 2,335,742 | 1.10% | 315.21M € | 2026-03-31 |
| Deerfield Management Company, L.P. | 機関 | 2,297,000 | 1.08% | 309.98M € | 2026-03-31 |
| Darwin Global Management Limited | 機関 | 2,211,018 | 1.04% | 298.38M € | 2026-03-31 |
| Logos Global Management, L.P. | 機関 | 2,000,000 | 0.94% | 269.90M € | 2026-03-31 |
| Alyeska Investment Group, L.P. | 機関 | 1,885,821 | 0.89% | 254.49M € | 2026-03-31 |
| National Bank Investments Inc. | 機関 | 1,749,000 | 0.82% | 236.03M € | 2026-03-31 |
| Charles Schwab Investment Management, Inc. | 機関 | 1,735,476 | 0.82% | 234.20M € | 2026-03-31 |
| Caligan Partners, LP | 機関 | 1,652,808 | 0.78% | 223.05M € | 2026-03-31 |
| Columbia Management Investment Advisers, LLC | 機関 | 1,579,793 | 0.74% | 213.19M € | 2026-03-31 |
| The Goldman Sachs Group, Inc. | 機関 | 1,560,805 | 0.73% | 210.63M € | 2026-03-31 |
| Two Sigma Investments, LP | 機関 | 1,558,807 | 0.73% | 210.36M € | 2026-03-31 |
| Westfield Capital Management Company, L.P. | 機関 | 1,556,578 | 0.73% | 210.06M € | 2026-03-31 |
| Bellevue Asset Management AG | 機関 | 1,544,456 | 0.73% | 208.42M € | 2026-03-31 |
| Integral Health Asset Management, LLC | 機関 | 1,500,000 | 0.71% | 202.43M € | 2026-03-31 |
| Farallon Capital Institutional Partners, L.P. | 機関 | 1,377,579 | 0.65% | 185.90M € | 2025-12-31 |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。